This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Giannini, G. Articles by Gulino, A. Search for Related Content PubMed PubMed Citation Articles by Giannini, G. Articles by Gulino, A.

HMGI(Y) and HMGI-C Genes Are Expressed in Neuroblastoma Cell Lines and Tumors and Affect Retinoic Acid Responsiveness¹

Department of Experimental Medicine and Pathology, University La Sapienza, 00161 Rome [G. G., E. R., M. Z., S. S., A. V., I. S., L. F., A. G.]; Department of Experimental Medicine, University of L’Aquila, 67100 L’Aquila [L. D. M.]; Molecular Oncogenesis Laboratory, Regina Elena Cancer Institute, 00158 Rome [M. C., G. P.]; Istituto di Genetica e Biochimica Evoluzionistica-Consiglio Nazionale delle Ricerche, 27100 Pavia [F. A. P.]; Department of Biochemistry, Biophysics and Chemistry of the Macromolecules, University of Trieste, 34127 Trieste [F. D.]; and IMN, Neuromed Institute, Pozzili [L. F., A. G.], Italy

HMGI-C and HMGI(Y) are architectural DNA-binding proteins that participate in the conformational regulation of active chromatin. Their pattern of expression in embryonal and adult tissues, the analysis of the "pygmy" phenotype induced by the inactivation of the HMGI-C gene, and their frequent qualitative or quantitative alteration in experimental and human tumors indicate their pivotal role in the control of cell growth, differentiation, and tumorigenesis in several tissues representative of the epithelial, mesenchymal, and hematopoietic lineages. In contrast, very little information is available on their expression and function in neural cells. Here, we investigated the expression of the HMGI(Y) and HMGI-C genes in neuroblastoma (NB), a tumor arising from an alteration of the normal differentiation of neural crest-derived cells and in embryonal and adult adrenal tissue. Although HMGI(Y) is constitutively expressed in the embryonal and adult adrenal gland and in all of the NB cell lines and ex vivo tumors examined, its regulation appears to be associated to growth inhibition and differentiation because we observed that HMGI(Y) expression is reduced by retinoic acid (RA) in several NB cell lines that are induced to differentiate into postmitotic neurons, whereas it is up-regulated by RA in cells that fail to differentiate. Furthermore, the decrease of HMGI(Y) expression observed in RA-induced growth arrest and differentiation is abrogated in cells that have been made insensitive to this drug by NMYC overexpression. In contrast, HMGI-C expression is down-regulated during the development of the adrenal gland, completely absent in the adult individual, and only detectable in a subset of ex vivo NB tumors and in RA-resistant NB cell lines. We provide evidence of a causal link between HMGI-C expression and resistance to the growth arrest induced by RA in NB cell lines because exogenous HMGI-C expression in HMGI-C-negative and RA-sensitive cells is sufficient to convert them into RA-resistant cells. Therefore, we suggest that HMGI-C and HMGI(Y) may participate in growth- and differentiation-related tumor progression events of neuroectodermal derivatives.

This article has been cited by other articles:

				Y. Chen and R. L. Stallings Differential Patterns of MicroRNA Expression in Neuroblastoma Are Correlated with Prognosis, Differentiation, and Apoptosis Cancer Res., February 1, 2007; 67(3): 976 - 983. [Abstract] [Full Text] [PDF]

				G. Giannini, F. Cerignoli, M. Mellone, I. Massimi, C. Ambrosi, C. Rinaldi, C. Dominici, L. Frati, I. Screpanti, and A. Gulino High Mobility Group A1 Is a Molecular Target for MYCN in Human Neuroblastoma Cancer Res., September 15, 2005; 65(18): 8308 - 8316. [Abstract] [Full Text] [PDF]

				A. R. Farina, M.-P. Masciulli, A. Tacconelli, L. Cappabianca, G. De Santis, A. Gulino, and A. R. Mackay All-trans-Retinoic Acid Induces Nuclear Factor {kappa}B Activation and Matrix Metalloproteinase-9 Expression and Enhances Basement Membrane Invasivity of Differentiation-resistant Human SK-N-BE 9N Neuroblastoma Cells Cell Growth Differ., August 1, 2002; 13(8): 343 - 354. [Abstract] [Full Text] [PDF]

				N. Aulner, C. Monod, G. Mandicourt, D. Jullien, O. Cuvier, A. Sall, S. Janssen, U. K. Laemmli, and E. Kas The AT-Hook Protein D1 Is Essential for Drosophila melanogaster Development and Is Implicated in Position-Effect Variegation Mol. Cell. Biol., February 15, 2002; 22(4): 1218 - 1232. [Abstract] [Full Text] [PDF]

				F. Cerignoli, X. Guo, B. Cardinali, C. Rinaldi, J. Casaletto, L. Frati, I. Screpanti, L. J. Gudas, A. Gulino, C. J. Thiele, et al. retSDR1, a Short-Chain Retinol Dehydrogenase/Reductase, Is Retinoic Acid-inducible and Frequently Deleted in Human Neuroblastoma Cell Lines Cancer Res., February 1, 2002; 62(4): 1196 - 1204. [Abstract] [Full Text] [PDF]

				K.-Y. Chau, N. Munshi, A. Keane-Myers, K.-W. Cheung-Chau, A. K.-F. Tai, G. Manfioletti, C. K. Dorey, D. Thanos, D. J. Zack, and S. J. Ono The Architectural Transcription Factor High Mobility Group I(Y) Participates in Photoreceptor-Specific Gene Expression J. Neurosci., October 1, 2000; 20(19): 7317 - 7324. [Abstract] [Full Text] [PDF]